Purchase Order W91YU016P0082
- Not listed
- This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
- This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
- The contract award is for the provision of critical medical functions, including generators and other nuclear medicine supplies, to the Veterans Integrated Service Network 8 (VISN 8) of the Department of Veterans Affairs (VA). The prime contractor is Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $90,010.00, awarded on November 29, 2017, with an ultimate completion date of November 18, 2020. The...
- This federal contract award is for the delivery of medical imaging products for nuclear medicine use at the Walter Reed National Military Medical Center. The prime contractor is Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The contract was awarded by the Defense Health Agency on a firm fixed price basis using Lantheus' Pharmaceuticals and Drugs Schedule contract. The potential value of the delivery order is $149,558.58, and it has a...
- This is a firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Lantheus Medical Imaging, Inc. for the provision of radiopharmaceuticals. The contract is valued at $141,137.33 and has a completion date of September 30, 2019. The contract was awarded on June 29, 2018 and is not set-aside. Lantheus Medical Imaging, a manufacturer of diagnostic medical imaging agents and products, is providing technetium-99m generators, xenon-133 gas, sestamibi vials, and...
- This firm fixed-price federal contract award to Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., is for the supply of medical imaging generators, contrast media, and radiopharmaceutical products to the Defense Health Agency (DHA). The $265,661.04 contract provides these critical diagnostic medical supplies to military treatment facilities, VA medical centers, and other federal healthcare institutions, with a period of performance through September 2025. The award is not...
- This federal contract award to Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., is for the delivery of radiopharmaceuticals and supplies to the Defense Health Agency (DHA). The $99,986.35 firm fixed-price contract has an ultimate completion date of September 30, 2025. Lantheus Medical Imaging, Inc. has secured multiple Indefinite Delivery Vehicles (IDVs) with the DHA, including a $6.5 million single-award Blanket Purchase Agreement (BPA) for diagnostic nuclear imaging...
- The Defense Health Agency awarded a $77,206.25 purchase order to Lantheus Medical Imaging, Inc. for radiopharmaceuticals on October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract, which carries no small business set-aside designation, supports medical imaging operations at Fort Bliss, Texas. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc. and based in North Billerica, Massachusetts, is a specialized manufacturer of diagnostic nuclear...
- This firm fixed-price purchase order, awarded by the U.S. Army Medical Command (MEDCOM) to Lantheus Medical Imaging, Inc., is for the supply of DEFINITY (perflutren lipid microsphere), a diagnostic medical imaging agent. The $84,339.36 contract has an ultimate completion date of August 14, 2018 and was awarded on February 6, 2018 without any small business set-aside designation. Lantheus Medical Imaging, Inc. is a subsidiary of the parent company Lantheus Holdings, Inc., both of which are...
- This contract award to Lantheus Medical Imaging, Inc. is a Blanket Purchase Agreement (BPA) call from the Defense Health Agency (DHA) for the delivery of radiopharmaceuticals. The contract has a ceiling value of $15,000.00 and a completion date of September 30, 2024. It is a firm fixed-price contract for the provision of critical nuclear medicine supplies and diagnostic imaging agents, primarily used in medical imaging procedures at military treatment facilities, VA medical centers, and other...
This federal contract award W91YU016P0082 was issued by the Medical Command (MEDCOM) of the U.S. Army to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The $241,498.00 firm fixed-price purchase order is for the delivery of radiopharmaceuticals, which are critical medical supplies used in diagnostic procedures at military treatment facilities and VA medical centers. The contract is a small business set-aside award and supports the Medical Command's efforts to provide specialized nuclear medicine products to the defense and veteran healthcare sectors. Lantheus Medical Imaging holds two significant federal contract Indefinite Delivery Vehicles (IDVs) with the Defense Health Agency for diagnostic nuclear imaging supplies and radiopharmaceuticals, further demonstrating the company's strategic positioning as a long-term, specialized supplier of critical medical imaging products to the U.S. government.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Radiopharmaceuticals | W91YU0-16-T-0014 | Department of the Army Medical Command | Award Notice 1/1 | 11/19/15, 1:59 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Change Order | $1.7k | 2/8/17 | |
| P00002 | Exercise an Option | $119.9k | 12/15/16 | |
| P00001 | Other Administrative Action | $0 | 1/29/16 | |
| Not listed | Not listed | $119.9k | 12/29/15 |